© Globe Newswire
30.12.2025
CBLL
LISTED
NASDAQ
Ceribell to Participate in the 44th Annual J.P. Morgan Healthcare Conference
News Preview
SUNNYVALE, Calif., Dec. 30, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced that Jane Chao, Ph.D., CEO and Co-founder, will present at the upcoming 44th Annual J.P. Morgan Healthc...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.12.2025
MDLN
LISTED
NASDAQ
Medline Announces Participation in J.P. Morgan 2026 Healthcare Conference
News Preview
NORTHFIELD, Ill., Dec. 30, 2025 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline”) (Nasdaq: MDLN) today announced that Jim Boyle, Chief Executive Officer, and Mike Drazin, Chief Financial Officer, are scheduled to present at the J.P. Morgan Healthcare Conference in San Francisco, Calif., on Tuesday, January 13, 2026, at 3:00 pm Pacific Time....
Themefolio
Profiler
Peergroup
© Globe Newswire
30.12.2025
RARE
LISTED
NASDAQ
Ultragenyx Completes Rolling Submission of Biologics License Application (BLA) to U.S. FDA for DTX401 AAV Gene Therapy for Glycogen Storage Disease Type Ia (GSDIa)
News Preview
If approved, DTX401 will be the first therapy approved to treat the underlying cause of GSDIa If approved, DTX401 will be the first therapy approved to treat the underlying cause of GSDIa...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© Globe Newswire
30.12.2025
PACB
LISTED
NASDAQ
PacBio to Present at the 44th Annual J.P. Morgan Healthcare Conference
News Preview
MENLO PARK, Calif., Dec. 30, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will be presenting at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026, at 10:30 AM PT (1:30 PM ET) in San Francisco, California....
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Globe Newswire
30.12.2025
TMCI
LISTED
NASDAQ
Treace to Present at 44th Annual J.P. Morgan Healthcare Conference
News Preview
PONTE VEDRA, Fla., Dec. 30, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today announced that John T. Treace, Chief Executive Officer, will present at the 44th Annua...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.12.2025
NAYA
LISTED
NASDAQ
INVO Fertility Aligns Executive Leadership Structure to Support Growth Strategy
News Preview
Terah Krigsvold to replace Andrea Goren as CFO, who is named chief business officer and CEO of INVO Centers LLC to focus on growth efforts Terah Krigsvold to replace Andrea Goren as CFO, who is named chief business officer and CEO of INVO Centers LLC to focus on growth efforts...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.12.2025
ADPT
LISTED
NASDAQ
Adaptive Biotechnologies to Present at the 44th Annual J.P. Morgan Healthcare Conference
News Preview
SEATTLE, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will be participating in the upcoming 44th Annual J.P. Morgan Healthcare...
Themefolio
Profiler
Peergroup
© ACCESS Newswire
30.12.2025
MIR
LISTED
TSX
MedMira Reports First Quarter Results FY2026
News Preview
HALIFAX, NOVA SCOTIA / ACCESS Newswire / December 30, 2025 / MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the quarter ended October 31, 2025.Corporate updateIn Q1 FY2026, the Company received the Health Canada approval for its Reveal® TP (Syphilis) rapid test. This major milestone allows the Company to offer t...
Themefolio
Profiler
Peergroup
© PR Newswire
30.12.2025
WWH
LISTED
LSE
Worldwide Healthcare Trust PLC - Transaction in Own Shares
News Preview
For immediate release
30 December 2025
WORLDWIDE HEALTHCARE TRUST PLC
(the "Company")
MARKET PURCHA...
Themefolio
Profiler
Peergroup
© EQS Newswire
30.12.2025
SKNY
LISTED
CSE
Transdermale und orale Alternativen zu Injektionen im Fokus – Skalierbare Technologieplattform mit Patentschutz
News Preview
EQS-Media / 30.12.2025 / 16:47 CET/CEST
Lir Life Sciences Corp. (ISIN: CA50206C1005 | WKN: A41QA9), LIR Life Sciences oder das Unternehmen, freut sich bekannt zu geben, dass die Bekämpfung der weltweiten Adipositas-Epidemie vor einem Wendepunkt stehen dürfte: Während injizierbare Medikamente derzeit den milliardenschweren “GLP-1-Markt” dominie......
Themefolio
Profiler
Peergroup
© PR Newswire
30.12.2025
PCRX
LISTED
NASDAQ
DOMA Perpetual Capital Management Announces Intent to Nominate Three Highly Qualified, Independent Director Candidates at 2026 Annual Meeting of Pacira BioSciences, Inc.
News Preview
Restates Position that Pacira's Board Should Conduct Formal Sales Process of the BusinessConsiders Current Executive Compensation and Spending Exorbitant and Unmerited Questions Whether the Board Has Exercised Appropriate Fiduciary OversightMIAMI, Dec. 30, 2025 /PRNewswire/ -- DOMA Perpetual Capital Management LLC (together with its affiliates, "D...
Themefolio
Profiler
Peergroup
© PR Newswire
30.12.2025
GLAB
LISTED
CSE
Canadian Investment Regulatory Organization Trade Resumption - GLAB
News Preview
VANCOUVER, BC, Dec. 30, 2025 /CNW/ - Trading resumes in:
Company: Gemina Laboratories Ltd.CSE Symbol: GLAB All Issues: YesResumption (ET): 10:30 AMCIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. CIRO is the nat...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© PR Newswire
30.12.2025
GLAB
LISTED
CSE
Canadian Investment Regulatory Organization Trading Halt - GLAB
News Preview
VANCOUVER, BC, Dec. 30, 2025 /CNW/ - The following issues have been halted by CIRO:
Company: Gemina Laboratories Ltd.CSE Symbol: GLABAll Issues: YesReason: DisseminationHalt Time (ET): 9:49 AMCIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensu...
Themefolio
Profiler
Peergroup
© BusinessWire
30.12.2025
ERF
LISTED
EURONEXT
Eurofins Scientific SE: Director/PDMR Shareholding
News Preview
Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below.
This notification is made in accordance with the European Market Abuse Regulation.
NOTIFICATION AND PUBLIC DISCLOSURE OF T...
Themefolio
Profiler
Peergroup
© PR Newswire
30.12.2025
LUCD
LISTED
NASDAQ
PAVmed Announces Reverse Stock Split
News Preview
NEW YORK, Dec. 30, 2025 /PRNewswire/ -- PAVmed Inc. (NASDAQ: PAVM) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, today announced it will conduct a 1-for-30 reverse stock split of its common stock (the "Common Stock"). The reverse sto...
Themefolio
Profiler
Peergroup
© PR Newswire
30.12.2025
CODX
LISTED
NASDAQ
Co-Diagnostics Announces Reverse Stock Split
News Preview
SALT LAKE CITY, Dec. 30, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that it has filed a Certificate of Amendment to its Certificate of Incorporation (the "Amendment") to effec...
Themefolio
Profiler
Peergroup
© PR Newswire
30.12.2025
PRFX
LISTED
NASDAQ
BladeRanger to Showcase Advanced Green Energy Technologies at Abu Dhabi Sustainability Week
News Preview
AI-driven monitoring and analytics solutions addressing the growing demand for energy efficiency in large-scale solar and critical infrastructure projects across the Middle East.TEL AVIV, Israel, Dec. 30, 2025 /PRNewswire/ -- BladeRanger (TASE: BLRN), a provider of drone-based inspection, maintenance, and AI-driven analytics solutions for green en...
Themefolio
Profiler
Peergroup
© PR Newswire
30.12.2025
WWH
LISTED
LSE
Worldwide Healthcare Trust PLC - Net Asset Value(s)
News Preview
WORLDWIDE HEALTHCARE TRUST PLC
LEI: 5493003YBCY4W1IMJU04
NET ASSET VALUE
The estimated un-audited net asset val...
Themefolio
Profiler
Peergroup
© Newsfile
30.12.2025
BUX
LISTED
CSE
BioMark Diagnostics Announces Appointment of Mr. James Lavender to Board of Directors
News Preview
Expanding U.S. market access with an experienced technology investor and AI-driven growth strategistVancouver, British Columbia--(Newsfile Corp. - December 30, 2025) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTCQB: BMKDF) ("BioMark" or the "Company"), a leading developer of liquid biopsy technologies for early cancer detection, is...
Themefolio
Profiler
Peergroup
© BusinessWire
30.12.2025
ZTS
LISTED
NYSE
Zoetis to Host Webcast and Conference Call on Fourth Quarter and Full Year 2025 Financial Results
News Preview
Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Thursday, February 12, 2026. Chief Executive Officer Kristin Peck and Executive Vice President and Chief Financial Officer Wetteny Joseph will review fourth quarter and full year 2025 financial results and respond to questions from financial analysts.
Investors a...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.12.2025
CLTX
LISTED
NASDAQ
Akari Therapeutics Issues 2025 End of Year Letter to Shareholders
News Preview
TAMPA, Fla. and LONDON, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel payloads today issued the following letter to shareholders from its President and Chief Executive Officer, Abizer Gaslightwala. ...
Themefolio
Profiler
Peergroup
© BusinessWire
30.12.2025
WGS
LISTED
NASDAQ
GeneDx to Present at the J.P. Morgan 2026 Healthcare Conference
News Preview
GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in the 44th Annual J.P. Morgan Healthcare Conference from January 12-15 in San Francisco, CA. Katherine Stueland, President and Chief Executive Officer, will participate in a presentation on Wedne...
Themefolio
Profiler
Peergroup
© BusinessWire
30.12.2025
TALK
LISTED
NASDAQ
Nearly 30% of Americans Say Mental Health Struggles Are Blocking 2026 Goals, New Talkspace Study Finds
News Preview
As the nation prepares to welcome 2026, new research reveals a significant "resolution gap": while Americans are setting ambitious goals for the New Year, nearly a third (28%) admit that mental health challenges are a major barrier to their success. To address this, Talkspace today announced the launch of “Own Your Now,” an integrated campaign des...
Themefolio
Profiler
Peergroup
© Newsfile
30.12.2025
PCLO
LISTED
TSX
PharmaCielo Announces Revocation of FFCTO and Related Corporate Matters
News Preview
All figures in Canadian dollars ($) unless otherwise specifiedToronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - December 30, 2025) - PharmaCielo Ltd. (TSXV: PCLO) (OTC Pink: PCLOF) ("PharmaCielo" or the "Company"), the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade cannabis extracts,...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.12.2025
SPRC
LISTED
NASDAQ
SciSparc: Neurothera Labs Granted Patent by Israeli Patent Office for its Proprietary Opioid-Based Patent Family to Enhance Pain Relief and Reduce Side Effects
News Preview
TEL AVIV, Israel, Dec. 30, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), today announced that NeuroThera Labs Inc. (TSXV: NTLX) ("NeuroThera"), a clinical-stage pharmaceutical company focused on developing novel treatments for central nervous system disorders, in which SciSparc holds a controlling interest of a...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.12.2025
SILO
LISTED
NASDAQ
Silo Pharma Executes Letter of Intent with Allucent to Support Phase 1 Clinical Development of SPC-15
News Preview
Planned SAD and MAD Studies Mark Key Clinical Inflection Point for Intranasal PTSD and Anxiety...
Themefolio
Profiler
Peergroup
© BusinessWire
30.12.2025
NEO
LISTED
NASDAQ
NeoGenomics Appoints Diagnostics and Lab Services Industry Veteran John P. “Jack” Kenny to its Board of Directors
News Preview
NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced the appointment of diagnostics and lab services industry veteran John P. “Jack” Kenny to its Board of Directors. Mr. Kenny is filling the seat vacated by Alison Hannah, MD, who is rotating off the Board after more tha...
Themefolio
Profiler
Peergroup
© PR Newswire
30.12.2025
CYPH
LISTED
NASDAQ
Cypherpunk Accelerates Zcash Accumulation; Increases Treasury Holdings to 290,062.67 ZEC
News Preview
CAMBRIDGE, Mass., Dec. 30, 2025 /PRNewswire/ -- Cypherpunk Technologies Inc. (Nasdaq: CYPH) ("Cypherpunk"), the privacy-focused technology company, today announced a significant expansion of its corporate treasury. The company has acquired an additional 56,418.09 ZEC for approximately $29 million at an average price of $514.02 per ZEC.
This latest...
Themefolio
Profiler
Peergroup
© PR Newswire
30.12.2025
CYPH
LISTED
NASDAQ
Cypherpunk Accelerates Zcash Accumulation; Increases Treasury Holdings to 290,062.67 ZEC
News Preview
CAMBRIDGE, Mass., Dec. 30, 2025 /PRNewswire/ -- Cypherpunk Technologies Inc. (Nasdaq: CYPH) ("Cypherpunk"), the privacy-focused technology company, today announced a significant expansion of its corporate treasury. The company has acquired an additional 56,418.09 ZEC for approximately $29 million at an average price of $514.02 per ZEC.
This latest...
Themefolio
Profiler
Peergroup
© PR Newswire
30.12.2025
CYPH
LISTED
NASDAQ
Cypherpunk Accelerates Zcash Accumulation; Increases Treasury Holdings to 290,062.67 ZEC
News Preview
CAMBRIDGE, Mass., Dec. 30, 2025 /PRNewswire/ -- Cypherpunk Technologies Inc. (Nasdaq: CYPH) ("Cypherpunk"), the privacy-focused technology company, today announced a significant expansion of its corporate treasury. The company has acquired an additional 56,418.09 ZEC for approximately $29 million at an average price of $514.02 per ZEC.This latest...
Themefolio
Profiler
Peergroup
© PR Newswire
30.12.2025
CYPH
LISTED
NASDAQ
Cypherpunk Accelerates Zcash Accumulation; Increases Treasury Holdings to 290,062.67 ZEC
News Preview
CAMBRIDGE, Mass., Dec. 30, 2025 /CNW/ -- Cypherpunk Technologies Inc. (Nasdaq: CYPH) ("Cypherpunk"), the privacy-focused technology company, today announced a significant expansion of its corporate treasury. The company has acquired an additional 56,418.09 ZEC for approximately $29 million at an average price of $514.02 per ZEC.This latest acquisi...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.12.2025
COGT
LISTED
NASDAQ
Cogent Biosciences Announces Submission of New Drug Application for Bezuclastinib in NonAdvanced Systemic Mastocytosis
News Preview
WALTHAM, Mass. and BOULDER, Colo., Dec. 30, 2025 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced it has submitted its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for bezuclastinib in NonAdv...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.12.2025
DNLI
LISTED
NASDAQ
The New England Journal of Medicine Publishes Phase 1/2 Study of Denali Therapeutics’ Tividenofusp Alfa (DNL310) for Hunter Syndrome (MPS II)
News Preview
SOUTH SAN FRANCISCO, Calif., Dec. 30, 2025 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (Nasdaq: DNLI) today announced the publication of results from the open-label Phase 1/2 clinical trial of its investigational, next-generation enzyme replacement therapy (ERT), tividenofusp alfa (DNL310), for the treatment of Hunter syndrome (mucopolysaccharid...
Themefolio
Profiler
Peergroup
© BusinessWire
30.12.2025
FONR
LISTED
NASDAQ
FONR Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of FONAR Corporation is Fair to Shareholders
News Preview
Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of FONAR Corporation (NASDAQ: FONR) to affiliates of Chief Executive Officer Timothy Damadian and certain executives and directors of the company for $19.00 per share for FONAR’s Class B common stock, and $6.34 per share for FONAR’s Class C common stock, is fair to FO...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.12.2025
XOMA
LISTED
NASDAQ
XOMA Royalty and Takeda Execute Strategic Royalty Sharing Transaction and Amend Existing Agreement for Mezagitamab
News Preview
Royalty sharing transaction brings 9 additional assets to XOMA Royalty's portfolio...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.12.2025
IFRX
LISTED
NASDAQ
InflaRx Provides Update on Phase 3 Data Analyses for Vilobelimab in Pyoderma Gangrenosum
News Preview
JENA, Germany, Dec. 30, 2025 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today outlined multiple data analyses of the Phase 3 study for vilobelimab in pyoderma gangrenosum (PG), which was terminated earlier this year after an Independent...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.12.2025
IMAB
LISTED
NASDAQ
NovaBridge to Ring the Nasdaq Opening Bell on Friday, January 2, 2026
News Preview
NovaBridge Also Included in the Highly Regarded Nasdaq Biotech Index, Emphasizing its Position as an Industry Leader...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.12.2025
ORNBV
LISTED
HEL
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
News Preview
ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS30 December 2025 at 14:00 EET ...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.12.2025
13
LISTED
HKSE
HUTCHMED Announces NDA Acceptance in China with Priority Review Status for Savolitinib for the treatment of Gastric Cancer Patients with MET Amplification
News Preview
— NDA supported by positive Phase II registration study data in Chinese patients; follows Breakthrough Therapy Designation granted in 2023 —...
Themefolio
Profiler
Peergroup
© ACCESS Newswire
30.12.2025
GLAB
LISTED
CSE
Debenture Offering and Delisting
News Preview
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC / ACCESS Newswire / December 30, 2025 / Gemina Laboratories Ltd. (CSE:GLAB) (the "Company" or "Gemina") announces it plans to proceed with a non-brokered private placement of secured, non-convertible debentures (each, a "Debe...
Themefolio
Profiler
Peergroup
© ACCESS Newswire
30.12.2025
MDCE
LISTED
OTC
Medical Care Technologies Inc. Updates Corporate Website to Highlight Accelerated Global Strategy for AI Mobile Applications
News Preview
MESA, AZ / ACCESS Newswire / December 30, 2025 / Medical Care Technologies Inc. (OTC Pink:MDCE) today announced that it has updated its corporate website, www.medicalcaretechnologies.com, to feature the Company's newly launched expedited approach to reaching international markets with its artificial intelligence ("AI") powered mobile appl...
Themefolio
Profiler
Peergroup
© ACCESS Newswire
30.12.2025
CVKD
LISTED
NASDAQ
Cadrenal's Pipeline Looks Less Like a Microcap and More Like an Emergency Response System
News Preview
PONTE VEDRA, FL / ACCESS Newswire / December 30, 2025 / Some companies enter a market because they see opportunity. Others step in because the situation has become unsustainable, and someone has to fix it. Cadrenal Therapeutics (NASDAQ:CVKD) falls into the second category. Modern medicine is carrying an anticoagulation burden it was never designed...
Themefolio
Profiler
Peergroup
© ACCESS Newswire
30.12.2025
AIML
LISTED
CSE
AIML Announces the Conclusion of Consulting Agreement and Leadership Transition for President & Chief Commercial Officer
News Preview
TORONTO, ON / ACCESS Newswire / December 30, 2025 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) has announced that its consulting agreement with Campfire Properties Inc. has concluded and that Peter Kendall is no longer serving as the Company's President and Chief Commercial Officer, effect...
Themefolio
Profiler
Peergroup
© ACCESS Newswire
30.12.2025
TGIF
LISTED
CSE
1933 Industries Provides Update on 2024 Debenture Conversions
News Preview
VANCOUVER, BC / ACCESS Newswire / December 30, 2025 / 1933 Industries Inc. (the "Company" or "1933 Industries") (CSE:TGIF)(OTCID:TGIFF) provides the following update regarding its unsecured convertible debentures issued in 2024 (the "2024 Debentures").Debenture Conversion StatusAs of December 22, 2025, the conversion d...
Themefolio
Profiler
Peergroup
© ACCESS Newswire
30.12.2025
ZOMDF
LISTED
OTC
Zomedica Launches Next-Generation VETGuardian PLUS(TM) Monitor, Expanding Core Monitoring Platform in Growing Veterinary Market
News Preview
New platform improves workflow efficiency, strengthens clinical confidence, and supports Zomedica's long-term growth strategy ANN ARBOR, MI / ACCESS Newswire / December 30, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), an animal health company offering innovative point-of-care diagnostic and therapeutic devi...
Themefolio
Profiler
Peergroup
© ACCESS Newswire
30.12.2025
CTTH
LISTED
OTC
CTT Pharmaceutical Holdings, Inc. Files Form S-1 Registration Statement and Advances Equity Line of Credit and Scientific Development Milestones
News Preview
TAMPA, FL / ACCESS Newswire / December 30, 2025 / CTT Pharmaceutical Holdings, Inc. (OTCQB:CTTH) today announces the filing of a Form S-1 registration statement with the United States Securities and Exchange Commission. The filing marks an important milestone in the Company's transition to fully reporting status and reflects management's commitment...
Themefolio
Profiler
Peergroup
© BusinessWire
30.12.2025
GALT
LISTED
NASDAQ
GALT Investors Have Opportunity to Join Galectin Therapeutics Inc. Fraud Investigation with The Schall Law Firm
News Preview
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Galectin Therapeutics Inc. (“Galectin” or “the Company”) (NASDAQ: GALT) for violations of the securities laws.
The investigation focuses on whether the Company issued false and/or misleading statements and/or fa...
Themefolio
Profiler
Peergroup
© BusinessWire
30.12.2025
INSM
LISTED
NASDAQ
INSM Investors Have Opportunity to Join Insmed Incorporated Fraud Investigation with the Schall Law Firm
News Preview
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Insmed Incorporated (“Insmed” or “the Company”) (NASDAQ: INSM) for violations of the securities laws.
The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to d...
Themefolio
Profiler
Peergroup
© PR Newswire
30.12.2025
CNC
LISTED
NYSE
Health Net Providing Special Assistance to Members Affected by the Atmospheric Rivers Due to the "2025 Late December Storms" in Los Angeles, Orange, Riverside, San Bernardino, San Diego, and Shasta Counties
News Preview
Health Net Assisting Members During State of EmergencySACRAMENTO, Calif., Dec. 29, 2025 /PRNewswire/ -- In response to Gov. Gavin Newsom's declared state of emergency in Los Angeles, Orange, Riverside, San Bernardino, San Diego, and Shasta Counties, Health Net, one of California's most experienced Medi-Cal managed care health plans and company of...
Themefolio
Profiler
Peergroup
© BusinessWire
30.12.2025
DVAX
LISTED
NASDAQ
CORRECTING and REPLACING Dynavax Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Dynavax Technologies Corporation - DVAX
News Preview
Please replace the release issued December 29, 2025 with the following corrected version due to multiple revisions.
The updated release reads:
DYNAVAX INVESTOR ALERT: KAHN SWICK & FOTI, LLC INVESTIGATES ADEQUACY OF PRICE AND PROCESS IN PROPOSED SALE OF DYNAVAX TECHNOLOGIES CORPORATION - DVAX
Former Attorney General of Louisiana Charles C...
Themefolio
Profiler
Peergroup
© BusinessWire
30.12.2025
DVAX
LISTED
NASDAQ
Dynavax Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Dynavax Technologies Corporation - DVAX
News Preview
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Dynavax Technologies Corporation (NasdaqGS: DVAX) to Sanofi (NYSE: SNY). Under the terms of the proposed transaction, shareholders of Cidara will receive $221.50 in cash for each share of Cid...
Themefolio
Profiler
Peergroup
© ACCESS Newswire
29.12.2025
TRNR
LISTED
NASDAQ
Interactive Strength Inc. (NASDAQ:TRNR) Provides Update on Sportstech Transaction
News Preview
AUSTIN, TEXAS / ACCESS Newswire / December 29, 2025 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or the "Company"), maker of innovative specialty fitness equipment under the Wattbike, CLMBR, and FORME brands, today provided an update regarding its previously announced, pending acquisition of, and working capital loan to, Sp...
Themefolio
Profiler
Peergroup
© PR Newswire
29.12.2025
PEN
LISTED
NYSE
Penumbra, Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference
News Preview
ALAMEDA, Calif., Dec. 29, 2025 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026.
Event: 44th...
Themefolio
Profiler
Peergroup
© Newsfile
29.12.2025
FONR
LISTED
NASDAQ
FONAR Signs Definitive Agreement for "Take Private" Sale to Acquisition Group Led by CEO
News Preview
FONAR stockholders to receive $19.00 per share of common stock, in an all-cash transactionMelville, New York--(Newsfile Corp. - December 29, 2025) - FONAR Corporation (NASDAQ: FONR) ("FONAR" or the "Company"), The Inventor of MR Scanning™, today confirmed that it entered into a definitive agreement on December 23, 2025 (the "Merger Agreement"...
Themefolio
Profiler
Peergroup
© BusinessWire
29.12.2025
VCYT
LISTED
NASDAQ
Veracyte to Participate in the 44th Annual J.P. Morgan Healthcare Conference
News Preview
Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, announced today that management will present at the 44th Annual J.P. Morgan Healthcare Conference on Thursday, January 15, 2026, at 9:45 a.m. Pacific Time.
Live audio webcasts of the company’s presentations will be available by visiting Veracyte’s website at http://investor.ver...
Themefolio
Profiler
Peergroup
© PR Newswire
29.12.2025
TXG
LISTED
NASDAQ
10x Genomics to Present at the 44th Annual J.P. Morgan Healthcare Conference
News Preview
PLEASANTON, Calif., Dec. 29, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that members of its management team will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026 at 8:15 a.m. Pacific Time....
Themefolio
Profiler
Peergroup
© BusinessWire
29.12.2025
PLSE
LISTED
NASDAQ
Pulse Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference
News Preview
Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel nPulse™ technology using its proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced plans to present at the upcoming 44th Annual J.P. Morgan 2026 Healthcare Conference in San Francisco.
Pulse Biosciences’ Management is scheduled to pr...
Themefolio
Profiler
Peergroup
© BusinessWire
29.12.2025
GH
LISTED
NASDAQ
Guardant Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference
News Preview
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will participate in the upcoming 44th Annual J.P. Morgan Healthcare Conference in San Francisco.
Guardant Health’s management is scheduled to present and participate in a Q&A session on Monday, January 12, at 3:45 p.m. Pacific Time / 6:45 p....
Themefolio
Profiler
Peergroup
© Globe Newswire
29.12.2025
RPRX
LISTED
NASDAQ
Royalty Pharma Acquires Remaining Royalty Interest in Roche’s Evrysdi for $240 Million and Potential Milestones
News Preview
Royalty Pharma will now own 100% of the 8% to 16% Evrysdi royalty following multiple transactions with PTC since 2020 Royalty Pharma will now own 100% of the 8% to 16% Evrysdi royalty following multiple transactions with PTC since 2020...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.12.2025
IRTC
LISTED
NASDAQ
iRhythm Technologies to Present at the 44th Annual J.P. Morgan Healthcare Conference
News Preview
iRhythm Technologies to Present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
